ClinicalTrials.Veeva

Menu

Risk Factors for COVID-19 Mortality (RF-COVID)

T

Teodoro Marcianò

Status

Terminated

Conditions

Acute Respiratory Distress Syndrome
Population at Risk
COVID-19 Virus Infection

Study type

Observational

Funder types

Other

Identifiers

NCT04786808
RF-COVID-AUSLPC

Details and patient eligibility

About

COVID-19 pandemic has deeply burdened hospitals all over the world. A two-stage disease has been hypothesized due to quick worsening of clinical status after 7-10 days from the beginning of first symptoms, generally flu-like symptoms. Predicting clinical worsening could help to address major efforts towards higher risk patients.

During the last year most observational studies, generally retrospective, has been conducted, identifying some risk factors such as age, obesity, male gender, cardiovascular disease, COPD, diabetes etc.

The study goal is to collect systematically a variegate amount of clinical, biometric, laboratory and radiological data from patients admitted to the Emergency Medicine Ward of Piacenza Hospital (Italy), in order to prospectively analyze what characteristics are associated to higher risk of mortality.

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Admission to the Emergency Medicine Ward from the Emergency Department of Piacenza Hospital (Italy)
  • Confirmed COVID-19 diagnosis through molecular test obtained from nasal-pharyngeal swabs in the Emergency Department
  • Age above 18

Exclusion criteria

  • inability to obtain an informed consent due to neurological conditions.
  • patient's refusal to sign the informed consent
  • inability of researchers to recruit the patient in the first 24 hours from the admission.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems